DC
RCPI

Davenport & Co’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Davenport & Co’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-404
Closed -$5.96K – 630
2014
Q2 		$5.96K Buy
+404
New +$7.01K ﹤0.01% 591

Other funds holding RCPI

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

Davenport & Co's RCPI Position: Q3 2014 in Review

Davenport & Co sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2014, closing a stake of 404 shares — an estimated $5.96K sold.

Davenport & Co first reported a position in RCPI in Q2 2014 and held it in 1 quarter. The position peaked at $5.96K in Q2 2014. 67 funds tracked by Wall St. Rank hold RCPI as of Q3 2014.

  • Davenport & Co reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Davenport & Co sold 404 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $5.96K.
  • Davenport & Co first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Davenport & Co's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $5.96K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Davenport & Co's 13F filing for Q3 2014, filed 10 Oct 2014.